American Family Children's Hospital
Paul M. Harari, MD close
Paul M. Harari, MD

For Patients

Need help selecting a doctor?
Call the Welcome Center at
(608) 821-4819 for personal assistance.

For Referring Physicians

How to refer a patient

Paul M. Harari, MD Print Friendly Page

Chair, Department of Human Oncology
Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Harari’s medical interests include radiation oncology, head and neck oncology, and oncology training and education.


Oncology (Radiation)

UW Health Clinics

UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map
UW Carbone Cancer Center
(608) 263-8500 | (800) 323-8942 | Map

Hospital Affiliation(s)

University Hospital (primary)
Veterans Hospital - Wm. S. Middleton Memorial, UnityPoint Health - Meriter (secondary)

UW School of Medicine and Public Health

Department of Human Oncology

Professional Certifications and Education

Board Certification Radiation Oncology
Residency The University of Arizona Medical Center, Tuscon, AZ
Internship University of California-Davis Medical Center, Sacramento, CA
Medical School University of Virginia School of Medicine, Charlottesville, VA, 1984


Best Doctors® in America 2015

UW Health Patient Experience Physician Champion Award 2015

Newsweek's Top Cancer Doctors 2015

Best Doctors® in America 2014

Best Doctors® in America 2013

Madison Magazine Top Docs 2012


Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.


Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.

Programs & Conditions


Dr. Harari's clinical and laboratory research focuses on treatment advances for head and neck cancer patients through precision radiation techniques and the use of molecular targeted growth inhibitors combined with radiation.

PubMed Articles
Harari PM . Why So Challenging to Personalize Radiation Dose? Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1012-1013
[PubMed ID: 28721882]
Ko HC Harari PM Sacotte RM Chen S Wieland AM Yu M Baschnagel AM Bruce JY Kimple RJ Witek ME . Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas. J Cancer Res Clin Oncol. 2017 Jul 27;
[PubMed ID: 28752235]
Ko HC Chen S Wieland AM Yu M Baschnagel AM Hartig GK Harari PM Witek ME . Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database. Head Neck. 2017 Jul 24;
[PubMed ID: 28737019]
Gessert TG Britt CJ Maas AMW Wieland AM Harari PM Hartig GK . Chondroradionecrosis of the larynx: 24-year University of Wisconsin experience. Head Neck. 2017 Jun;39(6):1189-1194
[PubMed ID: 28295829]
Pointer KB Ko HC Brower JV Witek ME Kimple RJ Lloyd RV Harari PM Baschnagel AM . Small cell carcinoma of the head and neck: An analysis of the National Cancer Database. Oral Oncol. 2017 Jun;69:92-98
[PubMed ID: 28559027]
Wojcieszynski AP Hill PM Rosenberg SA Hullett CR Labby ZE Paliwal B Geurts MW Bayliss RA Bayouth JE Harari PM Bassetti MF Baschnagel AM . Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans. Technol Cancer Res Treat. 2017 Jun;16(3):366-372
[PubMed ID: 28168936]
Harari PM Ritter MA van der Kogel AJ . Obituary and Tribute to John "Jack" Francis Fowler, PhD, DSc (1925-2016). Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):886-888
[PubMed ID: 28333004]
Iyer G Wang AR Brennan SR Bourgeois S Armstrong E Shah P Harari PM . Identification of stable housekeeping genes in response to ionizing radiation in cancer research. Sci Rep. 2017 Mar 6;7:43763
[PubMed ID: 28262749]
Iyer G Price J Bourgeois S Armstrong E Huang S Harari PM . Erratum to: Insulin-like growth factor 1 receptor mediated tyrosine 845 phosphorylation of epidermal growth factor receptor in the presence of monoclonal antibody cetuximab. BMC Cancer. 2016 Dec 1;16(1):928
[PubMed ID: 27905891]
Brower JV Chen S Bassetti MF Yu M Harari PM Ritter MA Baschnagel AM . Radiation Dose Escalation in Esophageal Cancer Revisited: A Contemporary Analysis of the National Cancer Data Base, 2004 to 2012. Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):985-993
[PubMed ID: 27869098]
Fayette J Wirth L Oprean C Udrea A Jimeno A Rischin D Nutting C Harari PM Csoszi T Cernea D O'Brien P Hanley WD Kapp AV Anderson M Penuel E McCall B Pirzkall A Vermorken JB . Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study). Front Oncol. 2016;6:232
[PubMed ID: 27843803]
Iyer G Price J Bourgeois S Armstrong E Huang S Harari PM . Insulin growth factor 1 like receptor (IGF-1R). BMC Cancer. 2016 Oct 6;16(1):773
[PubMed ID: 27716204]
Barasch S Mohindra P Hennrick K Hartig GK Harari PM Yang DT . Assessing p16 Status of Oropharyngeal Squamous Cell Carcinoma by Combined Assessment of the Number of Cells Stained and the Confluence of p16 Staining: A Validation by Clinical Outcomes. Am J Surg Pathol. 2016 Sep;40(9):1261-9
[PubMed ID: 27186851]
Bonner JA Giralt J Harari PM Baselga J Spencer S Bell D Raben D Liu J Schulten J Ang KK Rosenthal DI . Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial. Eur J Cancer. 2016 Sep;64:1-11
[PubMed ID: 27323346]
Bonner J Giralt J Harari P Spencer S Schulten J Hossain A Chang SC Chin S Baselga J . Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2016 Sep 1;142(9):842-9
[PubMed ID: 27389475]
Morris ZS Saha S Magnuson WJ Morris BA Borkenhagen JF Ching A Hirose G McMurry V Francis DM Harari PM Chappell R Tsuji S Ritter MA . Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Cancer. 2016 Aug 15;122(16):2487-95
[PubMed ID: 27203227]
Bar-Ad V Zhang QE Harari PM Axelrod R Rosenthal DI Trotti A Jones CU Garden AS Song G Foote RL Raben D Shenouda G Spencer SA Harris J Le QT . Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The┬áRTOG Experience. Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1346-54
[PubMed ID: 27212198]
Divi V Harris J Harari PM Cooper JS McHugh J Bell D Sturgis EM Cmelak AJ Suntharalingam M Raben D Kim H Spencer SA Laramore GE Trotti A Foote RL Schultz C Thorstad WL Zhang QE Le QT Holsinger FC . Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234). Cancer. 2016 Jul 15;
[PubMed ID: 27419843]
Morris ZS Guy EI Francis DM Gressett MM Werner LR Carmichael LL Yang RK Armstrong EA Huang S Navid F Gillies SD Korman A Hank JA Rakhmilevich AL Harari PM Sondel PM . In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments. Cancer Res. 2016 Jul 1;76(13):3929-41
[PubMed ID: 27197149]
Rosenthal DI Harari PM Giralt J Bell D Raben D Liu J Schulten J Ang KK Bonner JA . Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab. J Clin Oncol. 2016 Apr 20;34(12):1300-8
[PubMed ID: 26712222]